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Objective: The appropriateness of aortic valve–sparing operations in patients with Marfan syndrome has been
questioned. This study examines the long-term results of these operations in patients with Marfan syndrome.
Methods: From 1988 to 2006, 103 consecutive patients with Marfan syndrome (mean age, 37  12 years) and
aortic root aneurysm had aortic valve–sparing operations. Emergency surgery was performed in 11 patients: 8 for
acute type A aortic dissection and 3 for unexplained persistent chest pain. Fourteen patients also had mitral valve
surgery. The technique of aortic valve reimplantation was used in 77 patients, and aortic root remodeling was used
in 26 patients. Patients were followed prospectively and underwent annual echocardiographic studies. The mean
follow-up was 7.3  4.2 years and 100% complete.
Results: There was 1 operative death and 5 late deaths. Four of the 6 deaths were due to complications of aortic
dissections. The patients’ survival at 15 years was 87.2% compared with 95.6% for the general population of
Ontario matched for age and sex. Seven patients had important aortic insufficiency: 4 mild to moderate, 2 mod-
erate, and 1 moderate to severe. Freedom from greater than mild aortic insufficiency at 15 years was 79.2%. Three
patients, all after aortic root remodeling, had aortic valve replacement, 2 for aortic insufficiency and 1 for endo-
carditis. At the most recent follow-up, 97 patients were alive: 86 were in functional class I, and 11 were in func-
tional class II.
Conclusions: Aortic valve–sparing operations provided excellent clinical outcomes in this series of patients with
Marfan syndrome. Postoperatively, complications of aortic dissections were the leading cause of death.Earn CME credits at
http://cme.ctsnetjournals.org
Aortic root aneurysm is a cardinal manifestation of Marfan
syndrome and the most important determinant of prognosis.
Without surgical intervention, many patients die in the third
decade of their lives from complications of aortic root aneu-
rysm, such as aortic rupture, aortic dissection, and aortic in-
sufficiency (AI).1,2 Aortic root replacement dramatically
improves the survival of these patients.3 However, because
of their young age at the time when surgical intervention
is recommended, mechanical aortic valves are often used,
exposing them to a constant risk of hemorrhage, thrombo-
embolism, and prosthetic valve endocarditis.3 Aortic
valve–sparing operations are an alternative to aortic root re-
placement to treat aortic root aneurysm, and because the na-
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required.4,5 Although aortic valve–sparing operations have
been performed during the past 2 decades in a few centers,4,5
only recently have these procedures been widely adopted as
an alternative to aortic root replacement with mechanical or
biologic valved conduits in patients with Marfan syn-
drome.6,7 This study examines the long-term results of aortic
valve–sparing operations in patients with Marfan syndrome
by a single surgeon at a single institution.
MATERIALS AND METHODS
Aortic valve–sparing operations were performed in 103 consecutive
patients with Marfan syndrome at the Peter Munk Cardiac Centre at Tor-
onto General Hospital from July 1988 to December 2006. The diagnosis
of Marfan syndrome was made according to the Ghent criteria.8 The
patients’ mean age at the time of the operation was 37  12 years (range,
12–65 years), and 74 (72%) were men. The operation was elective in 92
patients and urgent/emergency in 11 patients. The reason for an urgent/
emergency operation was acute type A aortic dissection in 8 patients (2
in cardiogenic shock) and unexplained chest pain in 3 patients. In the re-
maining 92 patients, the main indication for surgical intervention was an
aortic root aneurysm of 50 mm or larger in diameter in 83 patients and se-
vere AI, mitral insufficiency, or both associated with an aortic root diameter
of less than 50 mm in 9 patients. Overall, the mean diameter of the aortic
sinuses was 53.3  4.8 mm (range, 41–70 mm). Three patients had previ-
ous replacement of the ascending aorta for acute type A aortic dissection.
Overall, 11 patients had type A aortic dissection, 8 had acute dissection,
and 3 had chronic dissection. Preoperative echocardiographic analysis dis-
closed that the aortic valve was tricuspid in 100 patients and bicuspid in 3
patients. Only 15 patients had moderate or severe AI, and 14 patients had
moderate or severe mitral insufficiency (1 with a heavily calcified mitral an-
nulus). Three patients (ages 42, 50, and 60 years) had coronary artery dis-
ease. In addition, 2 patients were diabetic, 1 patient had chronic renal failureardiovascular Surgery c Volume 138, Number 4 859
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on hemodialysis, and 2 patients had severe chronic obstructive pulmonary
disease (forced expiratory volume in 1 second,<1.0 L/s). Eleven patients
had severe pectus excavatum, and 2 patients had previous repair of this
deformity. The Review Ethics Board of the University Health Network
approved this study.
Operative Procedures
Two types of aortic valve–sparing operations, reimplantation of the aor-
tic valve and remodeling of the aortic root, were performed without a crite-
rion for performance of one or the other during the first decade of the study,
but during the second decade, only reimplantation of the aortic valve was
used because it was believed to be more durable in patients with Marfan syn-
drome.9 Remodeling of the aortic root was used in 26 patients, and reim-
plantation of the aortic valve was used in 77 patients. The size of the
graft used for remodeling of the aortic root was 27  2.4 mm (range, 24–
30 mm), and for reimplantation of the aortic valve, graft size was 30 
3.1 mm (range, 26–34 mm). Among patients who had reimplantation of
the aortic valve, 35 had a straight Dacron tube, and the more recent 42
had neoaortic sinuses created by plicating the tubular graft between com-
missures. Prolapse of 1 or more aortic cusps after reconstruction of the aortic
root was present in 30 patients and was corrected by shortening the free mar-
gin of the cusp by means of plication in the area of the nodule of Arantius or
by shortening and reinforcement of the free margin by weaving a double
layer of 6-0 Gore-Tex sutures (W. L. Gore & Associates, Inc, Tempe,
Ariz) from commissure to commissure. Only 1 patient required a second
pump run to correct mild-to-moderate AI caused by unrecognized cusp
prolapse.
In addition to the aortic valve–sparing operation, the mitral valve was re-
paired in 13 patients and replaced with a bioprosthetic valve in 1 patient who
also had reconstruction of the mitral annulus because of heavy calcification.
Four patients had coronary artery bypass, 3 because of coronary artery dis-
ease and 1 because of acute aortic dissection with a tear into the origin of the
right coronary artery and preoperative signs of inferior wall ischemia. Four
patients had replacement of the transverse aortic arch because of acute or
chronic aortic dissection. One patient also had concomitant repair of an ab-
dominal aortic aneurysm.
Patients who underwent concomitant mitral valve surgery were anticoa-
gulated with warfarin sodium during the first 3 postoperative months. Pa-
tients were discharged on a b-blocker agent, except for 5 patients who
received a calcium antagonist (2 patients) or an angiotensin-converting en-
zyme inhibitor (3 patients) because of intolerance to the b-blocker.
Follow-up
Patients were followed in our adult congenital heart clinic. Echocardio-
graphic analysis was performed annually. Imaging of the entire thoracic and
abdominal aorta was obtained annually in patients with aortic dissection and
every 3 to 5 years in the others. AI was graded as none, trivial, mild, mod-
erate, and severe on the basis of information from color flow mapping and
continuous-wave Doppler echocardiography.10 The median follow-up was
7.18 years (mean, 7.3  4.2 years) and was 100% complete.
Statistical Analysis
All data analyses were performed with SAS 9.1 software (SAS Institute,
Inc, Cary, NC). Categorical variables are reported as frequencies, and all
continuous variables are reported as means  standard deviations. Statisti-
cal comparison between the study groups was tested with the unpaired t test
or nonparametric Wilcoxon test for continuous variables and the c2 test or860 The Journal of Thoracic and Cardiovascular SurFisher’s exact test for categorical variables. The Kaplan–Meier method was
used to calculate estimates for long-term survival or freedom from morbid
events. Survival estimates for the age- and sex-matched Ontario general
population were obtained from the Life Table Template V1.2, a download-
able Excel spreadsheet available at http://www.healthinformation.on.ca. All
preoperative variables with a univariateP value of less than .25 or those with
known biologic significance but failing to meet this critical a level were sub-
mitted to the multivariable model for Cox regression analysis to determine
the independent multivariable predictors of late outcomes. Variable reten-
tion criteria in the model were set at a P value of .05.
RESULTS
One patient died the day after aortic valve reimplantation
of a new acute type B aortic dissection with malperfusion.
The dissection was not recognized until the patient showed
profound acidosis and irreversible shock.
One patient experienced cardiac arrest and rupture of the
liver during resuscitation and was successfully treated with
surgical repair of the liver. Ten patients required re-explora-
tion of the mediastinum for bleeding. Perioperative blood
transfusion was needed in 76 patients. Eleven patients had
transient postoperative atrial fibrillation. One patient re-
quired a permanent pacemaker after the aortic valve–sparing
operation, mitral valve repair, and myocardial revasculariza-
tion. There were no strokes, new myocardial infarctions,
new renal failures, respiratory failures, wound infections,
or any other serious postoperative complication.
Five patients died during the follow-up period: 1 of an
acute type B aortic dissection during pregnancy,11 1 of rup-
ture of the false lumen of a chronic type A dissection, 1 dur-
ing abdominal aortic surgery for chronic aortic dissection, 1
of chronic obstructive lung disease, and 1 of pneumonia.
Cox regression analysis did not identify any independent
predictor of death. The patients’ survival at 15 years was
87.2% compared with 95.6% for the general population
of Ontario matched for age and sex (Figure 1).
FIGURE 1. Long-term survival of patients with Marfan syndrome after
aortic valve–sparing operations compared with the general population of
Ontario matched for age and sex.gery c October 2009
David et al Acquired Cardiovascular Disease
A
C
DThree patients experienced a transient ischemic attack,
and computed tomographic scanning did not show any intra-
cranial abnormality. Two of these patients had chronic type
A aortic dissections with tears in the aortic arch. One patient
with known coronary artery disease had a myocardial infarc-
tion.
One patient had severe mitral insufficiency and underwent
successful mitral valve repair 8.3 years after the aortic
valve–sparing operation. One patient underwent replace-
ment of the entire thoracic and abdominal aorta because of
rupture of the false lumen and became paraplegic. This pa-
tient had infective endocarditis with an aortic root abscess
caused by Enterococcus faecalis 11.8 years postoperatively
and was successfully treated with aortic root replacement
with an aortic valve homograft. One patient had surgical in-
tervention for a ruptured false lumen of the abdominal aorta
and died at the time of the operation.
Two patients had aortic valve replacement for AI (moder-
ate in 1 and moderate to severe in 1) with mechanical valves,
and 1 patient had aortic root replacement for infective endo-
carditis with an aortic valve homograft. All 3 patients sur-
vived the reoperation. The original procedure had been
remodeling of the aortic root in all 3 patients. Figure 2 shows
the freedom from reoperation on the aortic root, which at 5,
10, and 15 years was 100%, 94.9%  3.5%, and 87.6% 
7.7%, respectively.
The latest echocardiographic study before death or reop-
eration in 102 patients who survived the operation showed
no AI in 33, trivial AI in 25, mild AI in 27, mild-to-moderate
AI in 4, moderate AI in 2, and moderate-to-severe AI in 1.
Thus 7 patients had greater than mild AI: 5 had undergone
aortic root remodeling, and 2 had undergone aortic valve re-
implantation. Only 2 of these 7 patients had had aortic cusp
repair, and only 1 had moderate or severe AI preoperatively.
Figure 3 shows the Kaplan–Meier estimates of freedom from
greater than mild AI in the entire group, which at 5, 10, and
FIGURE 2. Kaplan–Meier estimates on freedom from reoperation on the
aortic root after aortic valve–sparing operations.The Journal of Thoracic and C15 years were 100%, 92.5%  4.0%, and 79.2%  8.1%,
respectively. Freedom from greater than mild AI at 15 years
was 66.5%  13.2% after aortic root remodeling and
94.7%  5.1% after aortic valve reimplanation (P ¼ .12).
We could not identify any predictor of AI using univariate
or multivariate analyses. The mean follow-up of patients
who had remodeling was longer than in patients who had
reimplantation (9.7  2.8 vs 6.0  4.5 years, P ¼ .001).
At the latest follow-up contact, 97 patients were alive (3
had had aortic valve/root replacement): 86 were in New
York Heart Association functional class I, and 11 were in
class II.
DISCUSSION
Until a decade ago, many surgeons believed that aortic
valve–sparing operations should not be performed in pa-
tients with Marfan syndrome because the aortic cusps often
revealed fragmented fibrillin on indirect immunofluores-
cence examination.12,13 This abnormality was also seen in
patients with myxomatous degeneration of the mitral
valve.12,13 If repair of the mitral valve is the standard treat-
ment for patients with mitral regurgitation caused by myxo-
matous degeneration, why should aortic valve–sparing
operations not be the same for aortic root aneurysm? The
results of this study indicate that in our experience aortic
valve–sparing operations are as durable as mitral valve re-
pair for myxomatous disease.14
This study examines the clinical and echocardiographic
outcomes of 103 consecutive patients with Marfan syn-
drome and aortic root aneurysm who had aortic valve–spar-
ing operations during the past 2 decades. During the same
time interval, 49 patients with Marfan syndrome had aortic
root replacement with valved conduits, mostly during the
first decade of this study. The criterion based on the diameter
of the aortic sinuses to recommend surgical intervention in
patients with Marfan syndrome changed during this study.
FIGURE 3. Kaplan–Meier estimates on freedom from aortic insufficiency
(AI) greater than mild after aortic valve–sparing operations.ardiovascular Surgery c Volume 138, Number 4 861
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we reduced to 50 mm, and more valves could be saved.
We believe that the diameter of the aortic root is the most im-
portant determinant of the feasibility of aortic valve–sparing
operations because roots with diameters of greater than 60
mm often have a grossly dilated sinotubular junction and
aortic annulus, which damages the aortic cusps beyond ad-
visability of repair. Our decision to preserve or replace the
aortic valve is largely dependent on the quality of the aortic
cusps. Thinned and overstretched cusps with stress fenestra-
tions along the commissural areas are not preserved, and
aortic root replacement is deemed a better option. Normal
or near-normal aortic cusps or in cases in which only 1
cusp is abnormal (prolapse, large stress fenestration, or
both) are preserved by means of the aortic valve–sparing op-
eration, and the damaged cusp is repaired. Judicious use of
cusp repair has not affected the durability of aortic valve–
sparing operations in our experience.15 Remodeling of the
aortic root is technically less demanding than reimplantation
of the aortic valve and is functionally superior,16 but it is less
durable, particularly when the aortic annulus is dilated.9,17
Actually, we believe that even if the aortic annulus is normal
at the time of surgical intervention, it can dilate after remod-
eling of the aortic root and cause AI in young patients with
Marfan syndrome.9 Several studies have shown that aortic
valve function is more stable after reimplantation than after
remodeling.17-19 In the present study 26 patients had remod-
eling of the aortic root, and 5 had greater than mild AI, all
because of late dilation of the aortic annulus. Remodeling
is functionally superior to reimplantation because it pre-
serves the function of the aortic annulus and creates neo-
aortic sinuses.16 The aortic annulus becomes rigid after
reimplantation and functions like a stent for the aortic valve
cusps, but it is possible to create neoaortic sinuses by using
a graft 4 to 5 mm larger than needed for the size of the cusps
and plicating the spaces between commissures at the suban-
nular level, as well as at the level of the sinotubular junction.
This maneuver has been shown to reduce the velocity of clo-
sure of the aortic valve, and it might reduce stress on the
cusps.20,21 There is now a commercially available graft
with neoaortic sinuses, the Valsalva Graft (Sulzer Vascutek,
Renfrewshire, Scotland).22 There are no data on late out-
comes of aortic valve reimplantation with the Valsalva
Graft, but a small international series of 35 patients with
Marfan syndrome who had this graft showed a freedom
from reoperation caused by AI of 88.9% at 5 years.7
Comparative studies of retrospective series on aortic root
replacement with mechanical valves and aortic valve–spar-
ing operations in patients with Marfan syndrome have failed
to show superiority of one surgical approach over the
other.6,9,23 Aortic root replacement with mechanical valves
provide excellent freedom from reoperation caused by aortic
valve failure but is associated with a constant risk of throm-
boembolism, anticoagulation-related hemorrhage, and infec-862 The Journal of Thoracic and Cardiovascular Surtive endocarditis,3 whereas reoperation for AI is the major
problem with aortic valve–sparing operations.7,17-19,23
In the series by Gott and colleagues,13 of 271 patients who
had surgical intervention for aortic root aneurysm, the
15-year survival was 76%. This series included children,
48 patients with aortic dissections, 15 patients who had
aortic homografts placed, and 24 patients who had aortic
valve–sparing operations. There were 2 operative and 43 late
deaths, but only 10 caused by complications of aortic dissec-
tions (2 operative and 8 late), although the cause of death was
unknown in 12 patients. Functional class and urgent surgical
intervention were the only 2 independent predictors of late
death; aortic dissection was not.13 Complications of aortic
dissections claimed the lives of 4 of 6 patients who died in
our series, but we could not identify any predictor of mortal-
ity, probably because of the sample size. Reoperation for AI
after aortic valve–sparing operations has been uncommon in
our experience, but the follow-up is still limited considering
the age of our patients.
LIMITATIONS
This is a retrospective review of a prospectively followed
cohort of patients operated on by 1 surgeon at a single insti-
tution, and therefore the results might not be generalizable. It
is a descriptive study, and the only comparison made was
with the long-term survival of the general population
matched for age and sex. The number of patients who had
remodeling of the aortic root was small, and the duration
of follow-up after remodeling was longer than after reim-
plantation, thus precluding the determination of superiority
of one procedure over the other.
CONCLUSIONS
Aortic valve–sparing operations provide excellent long-
term valve function and low rates of valve-related complica-
tions in patients with Marfan syndrome. Reimplantation of
the aortic valve is likely more durable than remodeling of
the aortic root in these patients. Complications of aortic dis-
sections remain problematic in patients with Marfan syn-
drome after aortic valve–sparing operations and were the
most common cause of postoperative death in our series.
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Discussion
Dr Lars G. Svensson (Cleveland, Ohio). Dr David, congratula-
tions on your excellent results in developing these operations, and
thank you again for personally teaching me the reimplantation
operation.
We have had similar results with 234 patients, of whom 78
had Marfan syndrome, 9 had Loeys–Dietz syndrome, and 5
had Ehlers–Danlos syndrome, and no deaths have occurred using
our modification of the David reimplantation operation. Like
you, we have also become more aggressive in repairing leaflets,
with 35% being repaired in the last year. Indeed, in our own
analysis all our patients have had a freedom from reoperation,The Journal of Thoracic and Clike yours, of 96% at 9 years, with no failures in the Marfan re-
implantation reoperations. However, like you, we have reported
in the Annals a higher failure rate for the remodeling operation,
which leads to my first question. Do you not think we now have
enough information, including your greater experience, to say
that the remodeling operation should be abandoned and that
the David reimplantation operation is the standard of care for
connective tissue disorders, when feasible?
My second question relates to the reimplantation operation
and the fact that it requires meticulous technique and judgment
to achieve a valve without regurgitation and no complications.
A number of centers have reported difficulties, including postop-
erative ventricular septal defects and perforations of the anterior
leaflet of the mitral valve or the membranous septum. In patients
with connective tissue disorders requiring root annular reduc-
tions, we usually have used left ventricular outflow tract pledgets.
Even my good friend from Stanford tells me he uses pledgets
now in the septum in patients with Marfan syndrome, despite
his abhorring pledgets. Could you comment on any recent mod-
ifications you have made for maybe version 6 of your operation
and the use of pledgets for root reductions in patients with par-
ticularly fragile tissues?
Finally, we have no restrictions on size or degree of regurgitation
for the David reimplantation operation as long as the leaflets do not
have major perforations and can be repaired. In earlier articles you
did restrict the use of the procedure, and you did not comment in
your article on this. I was wondering whether with your greater ex-
perience you have changed your patient selection. Do you consider
all patients now for the operation?
Dr David. Thank you, Dr Svensson, for the comments. I have
not used the remodeling procedure in patients with Marfan syn-
drome since 1998. Once we discovered that some of them were di-
lating, we abandoned the procedure. Having said that, I think the
remodeling procedure is an easy operation. It can be done in just
over 1 hour, as opposed to reimplantation, which takes almost twice
as long and requires much more detail at multiple levels of the out-
flow tract and aortic root. Therefore I do remodeling in older pa-
tients who have aortic root aneurysm and a normal nondilated
aortic annulus but no longer in patients with Marfan syndrome or
even so-called form fruste Marfan syndrome.
Reimplantation is a complicated operation, and in patients
with fragile tissues, such as paper-thin outflow tracts, one has
to be careful with the suture line along the fibrous tissue of the
ventricular outflow tract to avoid holes in the mitral valve and
in a membranous septum. We have not changed the technique
much during the past 20 years as far as the suture line in the out-
flow tract. Every time we put a needle through a thin, delicate
membranous septum or intervalvular fibrous body, we do use
pledgets. We do not use pledgets in the muscular portion of
the left ventricular outflow tract. Another important technical as-
pect is not to use large needles or very large sutures for that an-
nuloplasty. The Dacron graft works as an annuloplasty. Therefore
as long as the graft is secured below the nadir of the cusps, it
should prevent dilatation. I usually use 4-0 polyester sutures
with a very fine needle for the suture beneath the aortic annulus
and try to use pledgets if the tissue is not thick enough.
Having said that, we have had 1 case of mild moderate mitral re-
gurgitation and 1 small ventricular septal defect. It was a millimeterardiovascular Surgery c Volume 138, Number 4 863
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Dhole in both cases. We know it is there; it bothered the cardiologist
and the sonographer more than the patient, but we have had this
complication.
Finally, as far as expanding the indications and including pa-
tients with bad cusps, I do not believe we are there yet. I was
very conservative in my first decade of experience. If I encountered
any gross abnormality in the cusps, I would do a Bentall procedure.
Over the past 12 or so, we became more aggressive, and if the pa-
tient does not want to have a mechanical valve—if he or she prefers
a tissue valve—then you go through the extra effort to repair the
aortic cusps. I have not gone to the extreme to put a patch yet in
the aortic valve because our previous experience with cusp aug-864 The Journal of Thoracic and Cardiovascular Sumentation with pericardium was not very good. However, rein-
forcing the free margin with fine Gore-Tex sutures has proved
to be durable and expands the rate of valve sparing in patients
with aortic root aneurysms. We just reviewed 64 patients who
had this technique of cusp repair, and we had no failure during
the first decade of follow-up. We use Gore-Tex sutures to rein-
force the free margins of cusps with large stress fenestration in
the commissural areas. Hopefully this publication will appear
in the Journal soon.
Dr Svensson. Thank you again for developing a great operation
for us.
Dr David. Thank you for your comments.rgery c October 2009
